In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?

Antimicrob Agents Chemother. 2011 May;55(5):2490-2. doi: 10.1128/AAC.01623-10. Epub 2011 Feb 14.

Abstract

Bacterial vaginosis is characterized by a shift of the physiological flora to a diverse spectrum of bacteria, where Gardnerella vaginalis and Atopobium vaginae are the most important markers. In this study, the antimicrobial activity of nifuratel against G. vaginalis, A. vaginae, and lactobacilli was compared with that of the two currently used antibiotics metronidazole and clindamycin. Results suggest that nifuratel has a better spectrum of activity, being highly active against G. vaginalis and A. vaginae without affecting lactobacilli.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Clindamycin / pharmacology
  • Clindamycin / therapeutic use
  • Female
  • Humans
  • Metronidazole / pharmacology
  • Metronidazole / therapeutic use
  • Microbial Sensitivity Tests
  • Nifuratel / pharmacology*
  • Nifuratel / therapeutic use*
  • Vagina / microbiology*
  • Vaginosis, Bacterial / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Clindamycin
  • Nifuratel